Wine, Beer, and Headache Tips

There have been a lot of news articles lately about wine and headaches. Last year we talked a bit about the different theories about why wine may – or may not – trigger headaches or migraine attacks.

Wine, Beer, and Headache TipsThere are also a lot of tips out there to help you avoid alcohol induced headaches in general.

For example, Dr. Seymour Diamond has recommended drinking two strong cups of coffee before you move on to alcohol. A little bit of honey in the coffee also may help, because the fructose in the honey helps the alcohol metabolize faster.

Trying something different may also help – some suggest a lighter coloured wine, or white instead of red. Also try wines that are lower in sugar.

Dr. Roshini Rajapaksa recommends a nondrowsy antihistamine prior to drinking wine.

But most of the advice seems to actually be – drink less. This includes not only simply avoiding alcohol, but also drinking water before you drink anything else – or alternating between water and alcohol.

Drinking water afterwards may help with the hangover, according to Dr. Dan Small.

With all the advice, remember that headaches related to alcohol have a number of causes. For example, if you get a headache right after drinking, it’s something different than the next-morning-hangover. If you have headaches like this, or any new headaches or symptoms, don’t just blame it on the drink – talk to a doctor who knows your medical history.

Have you tried any of this, or other advice? What have you found to be helpful?


Another (but different) Migraine Summit …

There is another migraine related summit taking place in July – and it’s a little different from the World Migraine Summit that you’re familiar with.

The Chronic Headache and Migraine SummitThe Chronic Headache and Migraine Summit is, of course, focused around chronic headache and migraine. You can sign up for free, and be involved from the 10th to 17th of July 2017. So if the dates work out well for you, check it out.

As with the Migraine World Summit, the talks are available for purchase, so you can watch them after the event. There are quite a few free goodies and discounts that come along with that.

One of the promoters of the summit explained it this way:

The Chronic Headache and Migraine Summit brings together thirty clinicians and researchers who have had success in helping people look deeper at the root issues that are causing their headaches or migraine pain, including hormone imbalances, digestive dysfunctions like food sensitivities or insufficiencies, emotional trauma, and more.

I think you’ll find a wide variety of information here, some of it more helpful than others. To get an idea what the presenters focus on, check the website here and scroll down to see the names.

For free, it’s certainly worth checking out. There will be a whole lot of information here, from a variety of perspectives, from many who have done a lot of research into health, headache, and migraine.

Check it out now – and be sure to sign up for free so you can at least check it out – The Chronic Headache and Migraine Summit


More Positive Results from the CGRP Migraine Treatments

It probable won’t be helpful to report in detail on every single CGRP inhibitor going through trials and coming to the market, but I will focus on one more today, just to point out that the competition is heating up.

CGRP targeting medications are not miracle drugs that will finally cure migraine. They are, however, another option – and a unique direction in treatment. That means that some people who have not been helped by other medications and treatments will have a new and different treatment to try.

Last month another trial was completed for fremanezumab, also known as TEV-48125. Fremanezumab is being developed by Teva Pharmaceutical Industries Ltd. Teva hopes to apply to the FDA for approval later this year, to use with both episodic and chronic migraine.

In this recent trial, the new medication cut down on days with migraine each month, as was reported with galcanezumab. In the past researchers have noted that fremanezumab has helped patients in clinical trials who were not having success with their current medication.

In the race to get to the market in the USA, one step ahead of both fremanezumab and galcanezumab is erenumab. The makers of this drug, Amgen, submitted a Biologics License Application (BLA) to the FDA in May.

But these won’t be the only three in this class of medication, if all goes well. Eptinezumab (formerly ALD403) also continues in clinical trials with positive results so far.

The good news is that each one of these drugs is a little different, and may help different people in different ways. Also, this may open up further migraine research and treatments that work better at targeting the migraine chain-reaction.

A cautionary note at this stage, however. The market-watchers are well aware that these medications mean billions of dollars – yes, billions. We can expect that the prices may be high, and also that the hype may outweigh the actual helpfulness of the new treatments.

But with these cautions in mind, many remain hopeful that many people will be losing fewer days to migraine – and that means more days to be productive, and to enjoy time with friends and family.


10 Headache and Migraine News Highlights from the past 3 Months (June 2017 edition)

Due to technical difficulties, recent articles have not been posted in a timely manner (or at all!) in social media. Normally I would highlight posts that have gotten the most “likes” on Facebook, but that would be a little unfair until the problem is fixed.

So, here’s a straightforward list of the articles that have been the most popular with you, guests at Headache and Migraine News. The most popular article, on TMD and migraine, is first on the list.

So if you’ve been missing recent posts, here are a few you’ll want to review…

  1. Migraine and TMD: A Complex Relationship (that should not be ignored)
  2. A Quick Update on Cefaly for Migraine
  3. Yes, it matters which Magnesium supplement you use…
  4. Vitamin B2 (riboflavin) for Migraine
  5. Candesartan for Migraine
  6. New Migraine Medication Ready to Apply to the FDA for Release
  7. Vestibular Migraine: What’s New
  8. Migraines and Blue Light – Or Maybe Green Light…
  9. Podcost: Migraine and Generalized Anxiety Disorder
  10. Back to Sleep: Simple Lifestyle Changes to Fight Chronic Migraine

Shades for Migraine

Here I am – in honour of the Shades for Migraine campaign today. I’m wearing my Theraspecs!

Shades for Migraine